NEW YORK (TheStreet) -- Welcome to Don Dion's Daily ETF Winners and Losers. Be sure to stop by each day to get a feel of who's winning and who's losing when it comes to ETFs.
iShares Dow Jones U.S. Home Construction Index Fund
Yesterday's jump in construction spending is helping to stem a rally in the home builders today, lifting ITB and the
SPDR S&P Homebuilder ETF
. Companies leading the ITB higher today include
Real estate remains a tricky region of the market to navigate. Investors should continue to use caution.
iPath Dow Jones UBS Sugar Total Return Subindex ETN
Sugar prices are seeing a nice pop today thanks to supply concerns from top producers, Brazil and India. The sweetener's rally has been staggering as prices approach near-30 year highs. This in turn has helped SGG rally along a near uninterrupted path which has persisted for months. The fund is now trading at new all-time highs.
The volatile nature of single commodity ETNs can be highlighted by SGG. The fund has managed to score new all time lows and new all time highs in 2010 alone.
iShares Dow Jones U.S. Healthcare Provider Index Fund
Providers and other components of the health care industry are seeing positive action today as investors prepare for a potential Congressional shake-up at the close to today's election.
Although markets are typically volatile during politically heated times, in this morning's feature I highlighted the
iShares Dow Jones U.S. Pharmaceuticals Index Fund
iShares Dow Jones U.S. Medical Devices Index Fund
as two possible plays for a mixed election turnout.
iShares MSCI Australia Index Fund
This morning, U.S. investors were treated to news that the Australian central bank unexpectedly raised interest rates. The move was done in hopes of curbing inflation.
Australia has been a major beneficiary of China's economic dominance as China looks to the nation as a source of raw materials and energy. Given the ties between the two nations, investors holding EWA should continue to monitor China's economic growth.
iPath S&P 500 VIX Short Term Futures ETN
Although political elections are typically considered volatile times for the stock market, the fear-based VIX index is not showing much in the way of strength today. Rather, the VXX and
iPath S&P VIX Mid-Term Futures ETN
have continued on their retreat lower.
Although it was holding up well versus VXX, the VXZ has recently taken a sharp turn downward, erasing most of its gains seen during its early summer run up.
ProShares UltraShort 20+ Year Treasury Bond Fund
While the newswires are buzzing today with election coverage, investors are piling into long-term Treasuries in anticipation that the
will announce additional quantitative easing Wednesday. This is helping to power the
iShares Barclays 20+ Year Treasury Bond Fund
iPath Dow Jones UBS Natural Gas Total Return Subindex ETN
Strong demand for natural gas exposure has caused the GAZ ETN to diverge from its underlying index, resulting in the generation of a substantial premium.
The effects of this premium can be seen today by GAZ's losses. The
United States Natural Gas Fund
, which is also designed to track natural gas futures, is trading in positive territory gaining 0.5%%.
GAZ does not effectively track its underlying index. Avoid this fund.
All prices as of 2:15 PM EST
Written by Don Dion in Williamstown, Mass.
At the time of publication, Dion Money Management owns iShares Dow Jones U.S. Pharmaceuticals Index Fund.
Don Dion is president and founder of
, a fee-based investment advisory firm to affluent individuals, families and nonprofit organizations, where he is responsible for setting investment policy, creating custom portfolios and overseeing the performance of client accounts. Founded in 1996 and based in Williamstown, Mass., Dion Money Management manages assets for clients in 49 states and 11 countries. Dion is a licensed attorney in Massachusetts and Maine and has more than 25 years' experience working in the financial markets, having founded and run two publicly traded companies before establishing Dion Money Management.
Dion also is publisher of the Fidelity Independent Adviser family of newsletters, which provides to a broad range of investors his commentary on the financial markets, with a specific emphasis on mutual funds and exchange-traded funds. With more than 100,000 subscribers in the U.S. and 29 other countries, Fidelity Independent Adviser publishes six monthly newsletters and three weekly newsletters. Its flagship publication, Fidelity Independent Adviser, has been published monthly for 11 years and reaches 40,000 subscribers.